| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3391037 | Seminarios de la Fundación Española de Reumatología | 2012 | 5 Pages |
Abstract
The need for a consistent and standardized assessment of the therapeutic effectiveness of the drugs tested and / or used for treatment of osteoarthritis (OA) led to the creation of a series of response criteria in which it can be easily assessed which patients respond or not to a given therapy. The Osteoarthritis Research Society International (OARSI) criteria and subsequently the Outcome Measures in Arthritis Clinical Trials-Osteoarthritis Research Society International (OMERACT-OARSI) criteria seek this assessment primarily based on three aspects that are essential for the patient: pain, physical function and the patient's global assessment. Its interest, scope and weaknesses are a matter of discussion of this commentary.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Ingrid Möller,